News

The approval, which is applicable to all 28 EU member states, has triggered $6m milestone payment to Curis from Genentech, a member of the Roche Group. Curis is

Commenting on the development Cipla managing director and global CEO Subhanu Saxena was quoted by The Economic Times as saying that the investment is aligned with the company’s

The research agreement involves the evaluation of partially refined mixtures as well as individual compounds. The aquatic environment is a source which consists of metabolically active organisms and

Under the terms of the long-term research agreement, Sobi will receive exclusive rights to commercialize XIAPEX in 28 European countries, including Switzerland, Norway, Iceland, 18 Central Eastern Europe/Commonwealth

The research agreement involves the evaluation of partially refined mixtures as well as individual compounds. The aquatic environment is a source which consists of metabolically active organisms and

Known as Fenofibric Acid Delayed-release Capsules, 45mg and 135mg is indicated for patients with mixed dyslipidemia and CHD or a CHD risk equivalent who are on optimal statin

Meeting the standards of child-resistant packaging, the new Kush containers are constructed with medical grade plastic, utilizing FDA approved material, and are BPA-free. Kush Bottles chief operating officer

A generic version of GlaxoSmithKline’s Lamictal ODT, the antiepileptic drug is indicated for the treatment of epilepsy and bipolar disorder. The company, which is the first to submit

The collaboration is focused on the development of a new generation of steroids and steroids related pharmaceuticals for rapid subcutaneous absorption. PharmaNova’s NovaSperse nanoparticle technology will be leveraged